Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Esperion Therapeutics Inc. (ESPR) has entered into a new financial arrangement with the Athyrium Fund.

Esperion Therapeutics Inc. (ESPR) has entered into a new financial arrangement with the Athyrium Fund.

老虎证券老虎证券2026/04/02 20:22
Show original
According to the terms of the agreement, the Athyrium Fund will have the right to receive tiered royalties based on Esperion's net sales, with rates ranging from 12% to 33%. In addition, the Athyrium Fund will also be eligible for a series of milestone payments. These financial benefits will continue to accrue until the Athyrium Fund achieves a total return equal to 2.0 times its initial investment.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Japan Central Bank inflation indicators accelerate, providing grounds for further interest rate hikes

An indicator used by the Bank of Japan to measure underlying inflation accelerated last month, significantly exceeding its target level, providing further justification for continuing to raise the benchmark interest rate.

智通财经•2026/09/25 06:51
Japan Central Bank inflation indicators accelerate, providing grounds for further interest rate hikes